UC

GHX Honors Top-Performing Healthcare Providers with 2023 Supply Chains of Distinction Award

Retrieved on: 
Tuesday, March 5, 2024
Hospital, Milford Regional Medical Center, Greater Baltimore Medical Center, Health, Brooklyn Hospital Center, Supply, Carteret Health Care, Southwest General Health Center, UW Health University Hospital, Newport News, Virginia, University, UC, Organization, Patient, Erie County Medical Center, Queen, Riverside Health System, Summit

LOUISVILLE, Colo., March 5, 2024 /PRNewswire/ -- Global Healthcare Exchange (GHX) today announced the inaugural class of its Supply Chains of Distinction Award for 2023, which recognizes top performing hospitals and health systems in North America.

Key Points: 
  • LOUISVILLE, Colo., March 5, 2024 /PRNewswire/ -- Global Healthcare Exchange (GHX) today announced the inaugural class of its Supply Chains of Distinction Award for 2023, which recognizes top performing hospitals and health systems in North America.
  • Industry-leading supply chains have evolved to become more automated, data-driven and resilient, giving rise to a set of best practice "perfect order" metrics that measure an organization's supply chain performance.
  • The Supply Chains of Distinction Award honors GHX Exchange-connected provider organizations that excelled in driving best-in-class supply chain operations.
  • The following organizations represent the class of 2023 Supply Chains of Distinction Award recipients.

Cadiz Inc. Announces Appointment of Barbara Lloyd to its Board of Directors

Retrieved on: 
Friday, March 1, 2024
Public policy, Woman, LOS, Audit, Lloyd's of London, Compensation, Irvine Ranch Water District, California State Assembly, City, Water resources, Government, MBA, California High-Speed Rail, Treasury, Stanford University, Climate change, University, UC, University of California, Davis, Public finance, Barclays, Veterans' affairs, Transport, KPMG, Water, Financial services

LOS ANGELES, March 1, 2024 /PRNewswire/ -- Cadiz, Inc. (NASDAQ: CDZI / CDZIP, the "Company") announced that Barbara Lloyd, a leading professional in the project finance industry with deep experience in public-private infrastructure financing in California, was appointed today to the Company's Board of Directors.

Key Points: 
  • "Cadiz will be the first Company in the world to convert natural gas pipelines for water conveyance.
  • Lloyd's appointment filled an existing vacancy on the Cadiz Board and is effective immediately.
  • The Board also appointed Lloyd to serve on the Audit & Risk and Compensation committees.
  • The appointment of Lloyd makes the Cadiz Board a majority women directors for the first time in the Company's history.

Broadvoice Awarded 2023 Global Excellence Award from Acquisition International Magazine

Retrieved on: 
Wednesday, February 28, 2024
Cloud, News, AI Global Media, PBX, Salesforce, UC, Microsoft, BroadVoice, Research, Webhook, ROI

LOS ANGELES, Feb. 28, 2024 /PRNewswire/ -- Broadvoice, an omnichannel contact center platform and unified communications provider for small and mid-market enterprises and BPOs, announced that it was named a winner of Acquisition International (AI) Magazine's 2023 Global Excellence Awards for Best SME Cloud Communications Company. 

Key Points: 
  • LOS ANGELES, Feb. 28, 2024 /PRNewswire/ -- Broadvoice , an omnichannel contact center platform and unified communications provider for small and mid-market enterprises and BPOs, announced that it was named a winner of Acquisition International (AI) Magazine's 2023 Global Excellence Awards for Best SME Cloud Communications Company.
  • They recognize innovative companies, teams and individuals who are driving change, surpassing expectations and excelling across the vast corporate landscape.
  • Broadvoice technology supports the ways small and mid-market businesses connect and interact with customers, regardless of the channel or location.
  • "Earning AI Magazine's Global Excellence Award confirms that we're delivering critical business-building solutions that help our partners effectively scale their operations and boost customer experience."

FDA Grants Fast Track Designation to 9MW2821

Retrieved on: 
Tuesday, February 27, 2024
DCR, Carcinoma, Immunotherapy, Cervical cancer, FDA, Food, ESCC, Fast track (FDA), PD-1, Apoptosis, ADC, FTD, UC, Cell membrane, Patient, Esophageal cancer, Fine chemical

SHANGHAI, Feb. 27, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announces that its self-developed novel ADC drug targeting Nectin-4 (R&D Code: 9MW2821) has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA) for the treatment of advanced, recurrent, or metastatic esophageal squamous cell carcinoma (hereinafter referred to as "ESCC").

Key Points: 
  • SHANGHAI, Feb. 27, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announces that its self-developed novel ADC drug targeting Nectin-4 (R&D Code: 9MW2821) has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA) for the treatment of advanced, recurrent, or metastatic esophageal squamous cell carcinoma (hereinafter referred to as "ESCC").
  • 9MW2821 is the world's first Nectin-4-targeting drug to disclose clinical efficacy data for the indication of EC.
  • After injection, 9MW2821 can specifically bind to Nectin-4 on the cell membrane surface, be internalized and release cytotoxic drug, and induce the apoptosis of tumor cells.
  • 9MW2821 is also the first to disclose preliminary clinical efficacy data for the indication of CC among drugs with the same target in the world.

Diversify Advisor Network Expands Leadership Team with the Addition of Kevin Bendix As Chief Legal Officer

Retrieved on: 
Tuesday, February 27, 2024
Intel, Freedom, Cisco, Samsung, Entrepreneurship, Kirkland & Ellis, UC, Kirkland, IP, Knowledge, UCLA School of Law, Marketing

SANDY, Utah, Feb. 27, 2024 /PRNewswire/ -- Diversify Advisor Network ("Diversify"), the advisor-founded and advisor-led wealth management firm, today announced the appointment of Kevin Bendix as Chief Legal Officer. In this newly created role, Mr. Bendix will report directly to Ryan Smith, Co-Founder and CEO of Diversify, and will work with the executive team to help execute the firm's vision. Leveraging his experience, as well as his familiarity with Diversify, Mr. Bendix will have an immediate positive impact on the firm's legal, M&A and technology strategies.

Key Points: 
  • Bendix Will Play Crucial Role in Executing Strategic Initiatives, Including Advisor Growth, M&A and Technology Buildout
    SANDY, Utah, Feb. 27, 2024 /PRNewswire/ -- Diversify Advisor Network ("Diversify"), the advisor-founded and advisor-led wealth management firm, today announced the appointment of Kevin Bendix as Chief Legal Officer.
  • In this newly created role, Mr. Bendix will report directly to Ryan Smith, Co-Founder and CEO of Diversify, and will work with the executive team to help execute the firm's vision.
  • Leveraging his experience, as well as his familiarity with Diversify, Mr. Bendix will have an immediate positive impact on the firm's legal, M&A and technology strategies.
  • "As we execute our multi-platform strategy and continue to enhance our custom tech stack, Kevin will be a valuable resource," said Mr. Smith.

British Technology company, C the Signs, selected by the White House-Backed Accelerator Programme, CancerX, to half Cancer Deaths

Retrieved on: 
Tuesday, February 27, 2024
Cancer Moonshot, AstraZeneca, Intel, Atrium Health, National Health Service, Quality of life, Hope, White, Risk, Social work, NHS, Health care, UC, Business, Patient, Accelerator, Dell Technologies, NHS England, Disease, Heart, Healthcare UK, Mortality, AWS, Cancer, Pharmaceutical industry

CancerX was unveiled by the White House in a landmark announcement last year to spearhead innovation in oncology.

Key Points: 
  • CancerX was unveiled by the White House in a landmark announcement last year to spearhead innovation in oncology.
  • The CancerX Accelerator programme aims to promote and fortify digital innovations in oncology by providing promising startups an opportunity to collaborate with leading cancer organizations.
  • C the Signs is an AI cancer prediction platform that identifies patients at risk of cancer at the earliest and most curable stage of the disease.
  • Launched by the White House, this initiative marks a significant step toward realizing the Cancer Moonshot's vision of a 50% reduction in cancer mortality.

British Technology company, C the Signs, selected by the White House-Backed Accelerator Programme, CancerX, to half Cancer Deaths

Retrieved on: 
Tuesday, February 27, 2024
Cancer Moonshot, AstraZeneca, Intel, Atrium Health, National Health Service, Quality of life, Hope, White, Risk, Social work, NHS, Health care, UC, Business, Patient, Accelerator, Dell Technologies, NHS England, Disease, Heart, Healthcare UK, Mortality, AWS, Cancer, Pharmaceutical industry

CancerX was unveiled by the White House in a landmark announcement last year to spearhead innovation in oncology.

Key Points: 
  • CancerX was unveiled by the White House in a landmark announcement last year to spearhead innovation in oncology.
  • The CancerX Accelerator programme aims to promote and fortify digital innovations in oncology by providing promising startups an opportunity to collaborate with leading cancer organizations.
  • C the Signs is an AI cancer prediction platform that identifies patients at risk of cancer at the earliest and most curable stage of the disease.
  • Launched by the White House, this initiative marks a significant step toward realizing the Cancer Moonshot's vision of a 50% reduction in cancer mortality.

Gesund.ai Partners with VALID AI and U.S. AI Safety Institute Consortium to Promote Development and Deployment of Trustworthy Medical Artificial Intelligence

Retrieved on: 
Monday, February 26, 2024
Collection, Medicine, Friction, Gen, Assistant, Drug development, Commerce, Government, Doctor of Philosophy, Safety, UC, NIST, Organization, Accelerator, Dime, Health equity, CIO, ONC, Research, Cancer, Partnership, Medical device

CAMBRIDGE, Mass., Feb. 26, 2024 /PRNewswire/ -- Gesund.ai, the company ensuring that medical artificial intelligence (AI) is safe and effective for all, today announced it has joined both VALID AI and the U.S. Artificial Intelligence Safety Institute Consortium (AISIC) as a member. The partnerships allow Gesund.ai to power the validation infrastructure for VALID AI member health systems, while working closely alongside government bodies like the Department of Commerce to help establish best practices for using medical AI.

Key Points: 
  • CAMBRIDGE, Mass., Feb. 26, 2024 /PRNewswire/ -- Gesund.ai , the company ensuring that medical artificial intelligence (AI) is safe and effective for all, today announced it has joined both VALID AI and the U.S.
  • Artificial Intelligence Safety Institute Consortium (AISIC) as a member.
  • VALID AI stands for Vision, Alignment, Learning, Implementation, and Dissemination of Validated Generative AI in Healthcare.
  • The AISIC brings together a consortium of AI creators, academics, government and industry researchers, and civil society organizations in support of the development and deployment of safe and trustworthy AI.

United Imaging Showcases AI-Driven Innovations and Expands European Presence at ECR 2024

Retrieved on: 
Friday, February 23, 2024
One Solution, UAI, ACS, Growth, Abdomen, Radiology, Perception, Bionics, Pelvis, SAT, University, ECR, Diagnosis, UMR, Neurology, Robotics, MRI, Software, CARE, CE, 3D, Radio, Extrapyramidal system, Brain, UII, SCAN, Safety, UDP, Yale University, Research, Workflow, Philosophy, MSK, 2D, Umi, AI, Cardiology, Thought, Signal-to-noise ratio, Joint, UC, University of California, Davis, Patient, DSA, Medical device

VIENNA, Feb. 23, 2024 /PRNewswire/ -- United Imaging, a global leader in medical technology, is showcasing its full portfolio of AI-empowered innovations at the European Society of Radiology (ECR) 2024 in Vienna, Austria.

Key Points: 
  • VIENNA, Feb. 23, 2024 /PRNewswire/ -- United Imaging, a global leader in medical technology, is showcasing its full portfolio of AI-empowered innovations at the European Society of Radiology (ECR) 2024 in Vienna, Austria.
  • At United Imaging, all our innovations are AI-driven, enhancing clinical workflows and supporting diverse scenarios, solidifying our commitment to delivering value to the global medical community.
  • In five years, United Imaging has introduced hundreds of systems and reached 16 European countries, offering efficient and professional service.
  • Highlighting the growth at ECR 2024, United Imaging will feature the uMR Jupiter 5T (not CE marked in EU) at ECR 2024, a revolutionary whole-body 5T MRI system.

Empowerly Raises $15M to Bolster Support for Students in an Increasingly Competitive Admissions Process

Retrieved on: 
Wednesday, February 21, 2024
SAN, University of Chicago, Student, AI, Intelligence, GPA, MIT, Ivy League, Mentorship, Harvard University, Parent, American Student Assistance, UC, Sequoia, Ecosystem, Knowledge, Machine learning, Stanford University, Carnegie Mellon University, Pressure, University of California, Berkeley

SAN FRANCISCO, Feb. 21, 2024 /PRNewswire/ -- Empowerly, a data-driven education technology company that provides personalized college and career guidance, today announced it has raised a $15 million financing round led by Conductive Ventures. The new funding will be used to continue expanding Empowerly's college counseling services with a focus on building out its artificial intelligence and machine learning product optimizations, such as the AI-powered Empowerly Score's predictive capabilities, scaling its team of admissions experts and data analytics, and preparing for the launch of a mobile app. To date, Empowerly has raised $30 million from investors, including Conductive Ventures, Goodwater Capital, FJ Labs, Scrum Ventures, Translink Capital, American Student Assistance, Spero Ventures, and Mentors Fund.

Key Points: 
  • With over 122,550 college applications read and reviewed, the company has helped thousands of students get accepted into their dream schools.
  • The Empowerly Score — the only predictive technology that can also quantify subjective material — provides students with a 360-degree view of how to be competitive against other applicants.
  • During the latest admissions cycle, an Empowerly student was admitted to every Ivy League college, including Harvard, Princeton, Yale, and Brown.
  • "Empowerly remains committed to providing every student with the resources, guidance, and expertise to navigate an incredibly challenging college admissions landscape," said Hanmei Wu, co-founder of Empowerly.